Sign in
4

Changes in Ownership

Sarepta Therapeutics, Inc. Filed Acc 0001209191-18-042389

SVP, Chief Commercial Officer sold 33,782 shares at $137.32 ($4,638,944)

  • SVP, Chief Commercial Officer acquired 33,782 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Cumbo Alexander · SVP, Chief Commercial Officer

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2018-07-09 Exercise or conversion : show line 1 in the form +11,924 $13.71 $163,478 40,690 D
2018-07-09 Sale : show line 2 in the form −11,924 $137.32 $1,637,404 28,766 D
2018-07-09 Exercise or conversion : show line 3 in the form +9,944 $13.71 $136,332 38,710 D
2018-07-09 Sale : show line 4 in the form −9,944 $137.32 $1,365,510 28,766 D
2018-07-09 Exercise or conversion : show line 5 in the form +11,914 $13.90 $165,605 40,680 D
2018-07-09 Sale : show line 6 in the form −11,914 $137.32 $1,636,030 28,766 D
Open-market sales · 33,782 sh · avg $137.32 · $4,638,944

Table II: Derivative

3 lines
Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
2018-07-09 Exercise or conversion : show line 7 in the form Stock option (right to buy) −11,924 $13.71 $163,478 $13.71 2026-02-28 11,924 3,850 D
2018-07-09 Exercise or conversion : show line 8 in the form Stock option (right to buy) −9,944 $13.71 $136,332 $13.71 2026-02-28 9,944 3,895 D
2018-07-09 Exercise or conversion : show line 9 in the form Stock option (right to buy) −11,914 $13.90 $165,605 $13.90 2025-02-27 11,914 2,250 D
Loading xslF345X03/doc4.xml…